OPTION 21

Financial services, namely funding, finance, and investing in the field of biomedical science, biomedical devices, biomedical services, biomedical innovation, and the biomedical industry; Financial services, namely, accepting and administering monetary charitable contributions for the purpose of funding groundbreaking research and investing in the biomedical industry and in biomedical science